ALK c.237G>A ;(p.E79=)

Variant ID: 2-30143289-C-T

NM_004304.4(ALK):c.237G>A;(p.E79=)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology.

International Journal Of Clinical Oncology
Naito, Yoichi Y; Mishima, Saori S; Akagi, Kiwamu K; Igarashi, Ataru A; Ikeda, Masafumi M; Okano, Susumu S; Kato, Shunsuke S; Takano, Tadao T; Tsuchihara, Katsuya K; Terashima, Keita K; Nishihara, Hiroshi H; Nishiyama, Hiroyki H; Hiyama, Eiso E; Hirasawa, Akira A; Hosoi, Hajime H; Maeda, Osamu O; Yatabe, Yasushi Y; Okamoto, Wataru W; Ono, Shigeru S; Kajiyama, Hiroaki H; Nagashima, Fumio F; Hatanaka, Yutaka Y; Miyachi, Mitsuru M; Kodera, Yasuhiro Y; Yoshino, Takayuki T; Taniguchi, Hiroya H
Publication Date: 2020-03

Variant appearance in text: ALK: E79E
PubMed Link: 31974683
Variant Present in the following documents:
  • Main text
View BVdb publication page